Atlas Trials

A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery

Clinical trial NCT07570940 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07570940
Sponsor
Mayo Clinic
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Artery DiseaseAtrial Fibrillation
Start date
2026-06-01
Primary completion
2030-06-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.